About Mangalam Drugs and Organics Ltd
Mangalam Drugs and Organics engaged in the manufacture and sale of Active Pharmaceutical Ingredients (API) for various therapeutic segments viz. Anti Malaria, Anti-Retrovirat, Anti-Hypertensive etc.
Founded
1972
CEO
Govardhan M Dhoot
Employees
480
HQ
Mumbai, Maharashtra
Finished Products
1Sale of Products
₹625.06Cr2Sales & Services
₹30.35Cr3Trading Sales
₹17.59Cr4Services related to Research &
₹9.39Cr5Gain on Exchange Rate Fluctuat
₹2.12Cr6Other Operating Income
₹1.24Cr7Duty Drawback Rebate
₹0.61Cr1–7 of 9
Raw Materials
1Cost of Material Consumed
₹395.32Cr2Purchases
₹18.33Cr3purchase
₹10.65CrAbout Mangalam Drugs and Organics Ltd
Mangalam Drugs and Organics engaged in the manufacture and sale of Active Pharmaceutical Ingredients (API) for various therapeutic segments viz. Anti Malaria, Anti-Retrovirat, Anti-Hypertensive etc.
Founded:1972
CEO:Govardhan M Dhoot
Employees:480
HQ:Mumbai, Maharashtra
Finished Products
1Sale of Products
₹625.06Cr2Sales & Services
₹30.35Cr3Trading Sales
₹17.59Cr4Services related to Research &
₹9.39Cr5Gain on Exchange Rate Fluctuat
₹2.12Cr6Other Operating Income
₹1.24Cr7Duty Drawback Rebate
₹0.61Cr1–7 of 9
Raw Materials
1Cost of Material Consumed
₹395.32Cr2Purchases
₹18.33Cr3purchase
₹10.65CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹80
52W Low
₹23
Volume28.61K
Avg VolumeN/A
Beta0.56
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
-1.25x
Valuation
P/B Ratio
0.50x
Valuation
EPS
₹-24.16
Valuation
Dividend Yield
0.00%
Valuation
ROE
-43.08%
Profitability
ROCE
-15.40%
Profitability
Revenue by Segment
Contribution & growth by business line
Manufacturing of Bulk DrugsRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
81.4%
International
18.6%
Domestic81.4%
Export18.6%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
1.02x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
0.0%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.